Conticchio Maria, Inchingolo Riccardo, Delvecchio Antonella, Ratti Francesca, Gelli Maximiliano, Anelli Massimiliano Ferdinando, Laurent Alexis, Vitali Giulio Cesare, Magistri Paolo, Assirati Giacomo, Felli Emanuele, Wakabayashi Taiga, Pessaux Patrick, Piardi Tullio, di Benedetto Fabrizio, de'Angelis Nicola, Briceño Javier, Rampoldi Antonio, Adam Renè, Cherqui Daniel, Aldrighetti Luca Antonio, Memeo Riccardo
Unit of Hepato-Pancreatic-Biliary Surgery, "F. Miulli" Regional General Hospital, Acquaviva Delle Fonti 70021, Italy.
Interventional Radiology Unit, Department of Radiology, "F. Miulli" Regional General Hospital, Acquaviva Delle Fonti 75100, Italy.
World J Hepatol. 2023 Dec 27;15(12):1307-1314. doi: 10.4254/wjh.v15.i12.1307.
Liver resection is the mainstay for a curative treatment for patients with resectable hepatocellular carcinoma (HCC), also in elderly population. Despite this, the evaluation of patient condition, liver function and extent of disease remains a demanding process with the aim to reduce postoperative morbidity and mortality.
To identify new perioperative risk factors that could be associated with higher 90- and 180-d mortality in elderly patients eligible for liver resection for HCC considering traditional perioperative risk scores and to develop a risk score.
A multicentric, retrospective study was performed by reviewing the medical records of patients aged 70 years or older who electively underwent liver resection for HCC; several independent variables correlated with death from all causes at 90 and 180 d were studied. The coefficients of Cox regression proportional-hazards model for six-month mortality were rounded to the nearest integer to assign risk factors' weights and derive the scoring algorithm.
Multivariate analysis found variables (American Society of Anesthesiology score, high rate of comorbidities, Mayo end stage liver disease score and size of biggest lesion) that had independent correlations with increased 90- and 180-d mortality. A clinical risk score was developed with survival profiles.
This score can aid in stratifying this population in order to assess who can benefit from surgical treatment in terms of postoperative mortality.
肝切除术是可切除肝细胞癌(HCC)患者,包括老年患者,根治性治疗的主要手段。尽管如此,评估患者状况、肝功能和疾病范围仍是一个要求较高的过程,目的是降低术后发病率和死亡率。
考虑传统围手术期风险评分,确定可能与符合HCC肝切除条件的老年患者90天和180天较高死亡率相关的新围手术期风险因素,并制定风险评分。
通过回顾70岁及以上因HCC接受择期肝切除术患者的病历进行多中心回顾性研究;研究了几个与90天和180天全因死亡相关的独立变量。将Cox回归比例风险模型6个月死亡率的系数四舍五入到最接近的整数,以确定风险因素的权重并推导评分算法。
多变量分析发现了与90天和180天死亡率增加独立相关的变量(美国麻醉医师协会评分、高合并症发生率、梅奥终末期肝病评分和最大病变大小)。制定了具有生存概况的临床风险评分。
该评分有助于对该人群进行分层,以评估哪些患者在术后死亡率方面可从手术治疗中获益。